The Division is actively involved in basic, translational and clinical research in benign and malignant blood disorders. Active areas of basic and translational research in the Division include molecular pathogenesis and animal models of AIDS-associated malignancies, multiple myeloma and lymphoma, development of targeted therapies for hematologic malignancies, cancer drug resistance, and clotting and bleeding disorders. In the area of clinical research, the Division is conducting clinical trials involving conventional agents, novel drugs and immunotherapy for the treatment of benign and malignant blood disorders.


Faculty Research Areas

Preet M. Chaudhary, MD, PhD
Adoptive Cellular Therapies
Chimeric Antigen Receptors
NF-kB Signaling
AIDS-Associated Malignancies
Animal Models of Lymphoma and Myeloma
Molecularly Targeted Therapies
Parkash S. Gill, MD
Role of Angiogenesis in Malignant Disease
Development of Novel Anti-Angiogenic Compounds
Therapeutic Aspects of Kaposi’s Sarcoma
Cage S. Johnson, MD
Red Blood Cell Enzyme Defects
Iron Deficiency
Kevin Kelly, MD, PhD
Malignant and Benign Hematologic Disorders
Preclinical Drug Development
Acute Myeloid Leukemia
Howard A. Liebman, MD
Heparin-Induced Thrombocytopenia in Vascular Surgery
Role of ADAMTS 13 in Vascular Disease
Thromboembolism Secondary to Chemotherapy and Cancer
Thrombopoeitic Agents in the Management of Immune Thrombocytopenic Purpura
Hittu Matta, PhD
KSHV-Associated Malignancies
Drug Development
Akil A. Merchant, MD
Sonic-Hedgehog Signaling
Acute Myeloid Leukemia
Ann F. Mohrbacher, MD
Multiple Myeloma
Immunotherapy of B-Cell Cancers
Phase I/II Trials of New Agents for Hematologic Malignancies
Casey L. O’Connell, MD
Blood Clotting Disorders
Cancer-Related Thrombosis
Vasu Punj, PhD
Giridharan Ramsingh, MD
Acute Leukemias
Drug Resistance
Leukemia Stem Cells
Anil Tulpule, MD
AIDS-Related Lymphoma
Kaposi’s Sarcoma in HIV Patients
Multi-Drug Resistance in Lymphoma
Ilene C. Weitz, MD
Hemostasis Abnormalities in Cancer Patients